| Contact Us|
Department of Pharmacological & Physiology
Room M 362 || 1402 South Grand Blvd
St. Louis, Missouri 63104
Primary Faculty Appointments
|Name||Degree Institution||Academic Interest|
|Michael Ariel, Ph.D.
|Washington University, 1980|
Sensorimotor information processing from visual and vestibular inputs that control eye movements.
|Joseph Baldassare, Ph.D.
|MIT and University of Pittsburgh, 1971|
Cell-cycle regulation and intracellular signal transduction mechanisms.
|Andrew A. Butler, Ph.D
University of Auckland, Auckland, New Zealand (1995)
Neural “nutrient sensing networks” control ingestive behaviors and metabolism to maintain metabolic homeostasis and a healthy body weight.
|John C. Chrivia, Ph.D.
|University of Washington, 1987|
Transcriptional reegulation by coactivators and nuclear receptors.
|Jane Cox, Ph.D.
|Ireland (Dublin), 1983|
Neurotransmitter receptors; molecular biology and developmental regulation of glutamate and P2X receptors.
|Decha Enkvetchakul, M.D.
|University of Missouri, Columbia, 1993|
Structural mechanisms underlying modulation of KirBac1.1 channel activity by membrane lipids and protons.
|Amy Harkins, Ph.D.
|Department of Biomedical Engineering,
Saint Louis University (secondary appointment)
University of Pennsylvania, 1993
Cellular and molecular mechanisms of synaptic vesicle release; calcium channels.
|Mark M. Knuepfer, Ph.D.
Autonomic pharmacology and physiology; central cardiovascular regulation; electrophysiology; effects of cocaine, stress and endotoxemia.
|Andrew Lechner, Ph.D.
|University of California, Riverside, 1977|
Pulmonary physiology; acute lung injury and the immunophysiology of sepsis.
|Heather Macarthur, Ph.D.
|William Harvey Research Institute, Saint Bartholomew's Medical College, London, 1994|
Vascular control mechanisms; endothelial mediators; sympathetic neurotransmission.
|Wendi S. Neckameyer, Ph.D.
|The Rockefeller University, 1985|
Development and function of neural circuitry.
|W. Michael Panneton, Ph.D.
|The Ohio State University, 1978|
The etiology of Parkinson disease; neural pathways mediating deep chronic pain; neural integration of somatautonomic reflexes (the diving response).
| Daniela Salvemini, Ph.D.
|University of London, 1990|
Role of reactive oxygen and nitrogen species and lipid mediators in acute and chronic pain and in the development of opiate antinociceptive tolerance.
|Willis K. Samson, Ph.D., D.Sc.
|University of Texas, 1979|
Neuropeptides and the control of cardiovascular function and stress hormone secretion
|Randy S. Sprague, M.D.
|Saint Louis University, 1976|
The role of the red blood cell as a determinant of vascular resistance.
|Alan H. Stephenson, Ph.D.
|Saint Louis University, 1986|
Vascular control mechanisms: eicosanoids, pulmonary & cardiovascular science.
|Mark M. Voigt, Ph.D.
|Saint Louis University, 1985|
Biochemical and molecular neuropharmcology and neuroscience; molecular biology and development regulation of purinergic receptors; development of sensory neurons in zeberafish.
|John K. Walker, PhD
|Ph.D. in Organic Chemistry
Indiana University, Bloomington, IN
|Medicinal Chemistry and Drug Design
Research Interests: Our laboratory is focused on the application of medicinal and synthetic organic chemistry toward the development of potential new therapeutic agents. We rely on structure based drug design and ligand based drug design techniques as well traditional medicinal chemistry principles to design these new molecules. Our research is highly collaborative and we are engaged in projects with a number of groups looking at new drug targets for anti-inflammatory, anti-bacterial and anti-caner agents.
|Thomas C. Westfall, Ph.D.
|West Virginia, 1962|
William Beaumont Professor, Chair Emeritus
|Gina Yosten, Ph.D.
|Ph.D., Saint Louis University|
Role of Orphan GPCRs in Obesity- and Diabetes-Associated Cardiovascular Disease
|Daniel S. Zahm, Ph.D.
Pennsylvania State University, 1982
Neuroanatomical and functional organization of basal forebrain; neurodegeneration, role of peptides in psychostimulant and opioid actions.